The Economics of RSV Prevention
WHO RSV Roadshow Web Event 4
On Wednesday 4th of December organised in collaboration with WHO and PATH the fourth Web Event “The Economics of RSV Prevention“.
What are the cost implications of RSV prevention?
Join us for an overview and discussion of the latest estimates around the costs, cost-effectiveness, and public health impact of RSV maternal vaccines and monoclonal antibodies for low- and middle-income markets.
Recording Available
Watch the Web Event Recording
Catch up on our recent web event, ‘The Economics of RSV Prevention’. Watch the full recording below to gain valuable insights from leading experts in the field.
Presentation slides
The WHO RSV Roadshow is based on the slide decks and toolkit created by the WHO, PATH, and other expert collaborators. All slide decks are free and available for anyone to use to spread the word about RSV.
Our host, speaker and expert reflection
Host
Dr. Leyla Kragten
Director ReSViNET Foundation – Zeist, The Netherlands
Dr. Leyla Kragten has been involved with ReSViNET from its inception, playing a key role in its development, shaping, and management. Her central involvement extends to all ReSViNET activities. With a background in Medical Biology, she earned her PhD in Metabolic Diseases in children from the Wilhelmina Children’s Hospital at the University Medical Center Utrecht, The Netherlands.
Speaker
Dr. Clint Pecenka
Director of Health Economics and Outcomes Research for Vaccine Innovation and Access at PATH)
Dr. Pecenka has expertise in economics, particularly in costing, impact analysis, cost-effectiveness, and demand forecasting for vaccines. In addition to his work on health economics, he has expertise in development, behavioral and experimental economics and policy.
Expert Reflection
DVM, MSc (PhD-c) Esperança Guimarães
Instituto Nacional de Saúde
Dr. Guimarães is a Vet by training, MSc in Epidemiology and PhD-candidate on Tropical diseases and Global Health. She works at the INS (the National Institute of Health) as investigator and project officer. Regarding research, Esperança has been working on project design and implementation of Costing, Cost-effectiveness of vaccines, child and maternal immunization, and gastroenteritis studies.
Upcoming Events
WHO RSV Roadshow Web Event 5
We are very excited to announce the fifth WHO RSV Roadshow is coming on the 15th of January 2025. This RSV Roadshow Web Series is hosted by the World Health Organization (WHO) in collaboration with PATH and the ReSViNET Foundation. Together we will organise 7 monthly educational Web Events covering RSV disease and burden, new immunisation products, delivery considerations, and more!
Topic: The RSV Immunisation Pipeline to Global Policy and Programmatic Use
Date: 15 January 2025
Time: 15:00 – 16:00 CET
Web Events Program 2024 – 2025
